New anti-viral drug ‘doubles hepatitis C treatment’s effectiveness’
August 9th, 2010 - 12:45 pm ICT by ANILondon, Aug 9 (ANI): Adding a new antiviral drug to the standard treatment for hepatitis C considerably increases the cure rate in severe patients, according to a new study.
Paul Kwo of Indiana University School of Medicine reported that the drug nearly doubled the treatment’s effectiveness when given for 48 weeks.
Hepatitis C infections occur mainly through transmission of infected blood, such as via injection drug use, and there is no vaccine. It is a leading cause of liver cancer and liver transplantation.
Adding the drug boceprevir increased the cure rate to as high as 75 percent in those who received 48 weeks of the three-drug combination therapy.
These patients tested negative for evidence of the virus six months after the end of treatment.
“Based on this phase 2 study, it appears that if this drug receives final approval approximately two-thirds of patients will be able to be treated successfully with 28 weeks of treatment and one-third will need 48 weeks of treatment, though this will require confirmation from the phase 3 trials, from which preliminary results were recently released,” said Kwo.
The study is published Monday in the online edition of the journal The Lancet. (ANI)
- Drug cocktail shows promise against hepatitis C - Mar 31, 2011
- Clinical trial offers hope for Hepatitis C patients - Mar 15, 2011
- New find may offer protection against hepatitis C treatment-related anemia - Jan 26, 2011
- Integrate Hepatitis C testing with HIV: NGOs - Oct 21, 2011
- New generation of drugs to cure hepatitis C - Aug 14, 2010
- Coffee can cure hepatitis C - Jun 08, 2011
- New hope for hepatitis C sufferers - Apr 09, 2010
- Agartala kicks off mission to become Hepatitis free - Apr 15, 2012
- Added anti-viral boosts response, shortens hepatitis C treatment duration - Apr 30, 2009
- Coffee may be good for chronic hepatitis C patients - Oct 21, 2009
- First human receives new antibody aimed at neutralizing Hepatitis C virus - Aug 07, 2009
- New therapy could help beat Hepatitis C virus - Jan 17, 2012
- Wrong treatment leads to Hepatitis C cases in China - Mar 03, 2012
- Extending hepatitis C treatment for liver transplant patients may be beneficial - Nov 01, 2009
- Success of hepatitis C treatment may depend on genetic variant - Jun 13, 2010
Tags: antiviral drug, cause of liver cancer, combination therapy, drug combination, drug use, final approval, hepatitis, hepatitis c, hepatitis c infections, hepatitis c treatment, indiana university school, indiana university school of medicine, kwo, lancet, liver transplantation, phase 2, phase 3, preliminary results, school of medicine, two thirds